Dyne Therapeutics Inc (DYN)
24.87
+1.01
(+4.23%)
USD |
NASDAQ |
Apr 22, 16:00
24.86
-0.01
(-0.04%)
Pre-Market: 20:00
Dyne Therapeutics Total Liabilities (Quarterly): 73.79M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 73.79M |
| September 30, 2023 | 53.21M |
| June 30, 2023 | 44.54M |
| March 31, 2023 | 46.71M |
| December 31, 2022 | 53.96M |
| September 30, 2022 | 49.94M |
| June 30, 2022 | 52.97M |
| March 31, 2022 | 51.30M |
| Date | Value |
|---|---|
| December 31, 2021 | 57.47M |
| September 30, 2021 | 52.76M |
| June 30, 2021 | 14.55M |
| March 31, 2021 | 13.45M |
| December 31, 2020 | 10.97M |
| September 30, 2020 | 14.63M |
| June 30, 2020 | 14.29M |
| December 31, 2019 | 2.40M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.40M
Minimum
Dec 2019
73.79M
Maximum
Dec 2023
37.93M
Average
48.32M
Median
Total Liabilities (Quarterly) Benchmarks
| Rocket Pharmaceuticals Inc | 73.77M |
| Solid Biosciences Inc | 38.46M |
| Avidity Biosciences Inc | 127.79M |
| Sana Biotechnology Inc | 277.79M |
| Tenaya Therapeutics Inc | 31.09M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 165.08M |
| Shareholders Equity (Quarterly) | 91.29M |